Expert Radar
Dr. Gordon Brown, DO, FACOS
Medical Director, Summit Health (New Providence, NJ)
Bachelor of Arts, Boston University
Dr. Gordon A. Brown has 16 years of experience in Urology. He earned his BA in Cell and Molecular Biology from Boston University and his DO from Rowan University School of Osteopathic Medicine. He completed two residencies in General Surgery and Urology at the Rowan University School of Osteopathic Medicine and a fellowship in Urologic Oncology at the University of Texas MD Anderson Cancer Center. Currently, he serves as a Physician and Director of the Center for Advanced Therapeutics at New Jersey Urology and as Program Director of Urologic Surgery Residency at Rowan University School of Osteopathic Medicine.
g********@n*****.com
(856) ***-****
Voorhees, New Jersey
Get a FREE Demo of Dr. Gordon Brown, DO, FACOS's Radar Profile
Review this expert's litigation history, supporting legal docs, publications, professional background, and more.
Comprehensive data on expert witnesses: Access detailed litigation history and performance metrics.
Swift assessment: Quickly evaluate an expert's track record.
Informed decisions: Make better choices when selecting or challenging expert witnesses in any case.
Expert Witness Activity
Plaintiff Cases
Defense Cases
Expert Challenges
Deposition Transcripts
Publications
75
Media & News
437
Social Media Mentions
Expert Institute operates independently and objectively as an expert witness data provider. Expert Institute does not employ, endorse, or have an affiliation with any expert witnesses for which data is provided.
Case Name | Role | Filed Date |
---|
Defense
Plaintiff
0
25
50
75
100
2000
0
2002
0
2004
0
2006
0
2008
0
2010
0
0
25
50
75
100
Radar found 75 records
Title | Type |
---|---|
Apalutamide for High-Risk Localized Prostate Cancer Following Radical Prostatectomy (Apa-RP) | Journal Article |
Correction to: Introduction and validation of the open symptom framework: a public domain modular framework for patient-reported measurement of symptoms related to cancer and its treatment (Quality of Life Research, (2024), 33, 9, (2349-2358), 10.1007/s11136-024-03656-6) | Erratum |
Introduction and validation of the open symptom framework: a public domain modular framework for patient-reported measurement of symptoms related to cancer and its treatment | Journal Article |
Radar monitors a wide array of publication sources, including links to abstracts.
Review book chapters, journal articles, research papers, trade publications, technical reports, conference proceedings, and more.
Radar found 437 records
Title | Description |
---|---|
American Urological Association (AUA 2024) | Aug 26, 2024 ----- Oncology . Home Therapeutic Areas Oncology Congresses; Current ... Neal Shore, Jason Hafron, Daniel Saltzstein, Gordon Brown , Laurence ... |
Apalutamide for High-Risk Localized Prostate Cancer ... | Aug 13, 2024 ----- Authots: Neal Shore, Jason Hafron, Daniel Saltzstein, Gordon Brown ... 2024 Carolina Urologic Research Center, LLC | All Rights Reserved ... |
Myrtle Beach, SC | Authots: Neal Shore, Jason Hafron, Daniel Saltzstein, Gordon Brown , Laurence ... 2024 Carolina Urologic Research Center, LLC | All Rights Reserved ... |
Radar scours thousands of media and news sources across the internet 24/7.
Access interviews, webinars, TV appearances, blog posts, columns, whitepapers, PDFs, profressional profiles, and more.
Institution | Degree Type |
---|---|
Boston University | Bachelor of Arts |
Rowan University School of Osteopathic Medicine | Doctor of Osteopathic Medicine |
Title | Employer |
---|---|
Medical Director | Summit Health (New Providence, NJ) |
Director | New Jersey Urology (Sewell, NJ) |
Physician | New Jersey Urology (Sewell, NJ) |
Access detailed litigation history and performance metrics.
Access your Radar profile through Expert iQ, our secure, cloud-based platform that hosts AI-driven insights.
Delivered in 5–7 business days
Receive your profile swiftly, with Radar gathering intelligence from thousands of data points.
24/7 monitoring for 12 months
Stay informed with continuous monitoring and live alerts, ensuring your profile is always up-to-date.